Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: an analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 trial. [electronic resource]
Producer: 20090925Description: 4268-73 p. digitalISSN:- 1527-7755
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Canada
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Chemotherapy, Adjuvant
- Cisplatin -- administration & dosage
- Humans
- Lung Neoplasms -- drug therapy
- Outcome Assessment, Health Care -- methods
- Prospective Studies
- Quality of Life
- Randomized Controlled Trials as Topic
- Surveys and Questionnaires
- Survival Analysis
- Vinblastine -- administration & dosage
- Vinorelbine
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.